How to Check Galaxy Medicare IPO Allotment Status?

Galaxy Medicare Limited manufactures and exports medical devices, POP bandages, and surgical dressings in India, incorporated in July 1992. The company operates with 190 employees as of March 2025, specializing in surgical dressings, plaster of Paris bandages, adhesive tapes, compression bandages, and wound care solutions while maintaining 27 registered trademarks in India and serving domestic and international markets through manufacturing and branding for flagship brands, OEM services, institutional sales via government tenders, and international exports, complying with ISO 9001:2015 and ISO 13485:2016 certifications.

The Galaxy Medicare IPO came with a total issue size of ₹22.31 crore, comprising a fresh issue of 0.33 crore shares aggregating to ₹17.86 crore and offer for sale of 0.08 crore shares aggregating to ₹4.45 crore. The IPO opened on September 10, 2025, and closed on September 12, 2025. The allotment for the Galaxy Medicare IPO is expected to be finalized on Monday, September 15, 2025. The Galaxy Medicare IPO share price band was set at ₹51 to ₹54 per share.
 

Don’t Miss Out on the Next Big IPO – Invest With Just a Few Clicks!

Open Account Now

Steps to Check Galaxy Medicare IPO Allotment Status on Registrar Site

• Visit the Cameo Corporate Services Ltd. website  
• Select "Galaxy Medicare" from the dropdown menu on the allotment status page
• Enter your PAN ID, Demat Account Number, or Application Number in the designated field
• Complete the captcha verification process and click on the "Submit" button to view your allotment status

Steps to Check Galaxy Medicare IPO Allotment Status on NSE

• Navigate to the NSE SME IPO Allotment Status Page
• Select the issue type: equity/debt
• Choose "Galaxy Medicare" from the list of active IPOs in the dropdown menu
• Input your Application Number and PAN ID in the required fields
• Verify the captcha and click "Search" to check your allotment status

Galaxy Medicare IPO Subscription Status

Galaxy Medicare IPO received weak investor interest, being subscribed 1.83 times overall. The subscription showed limited confidence across categories in the Galaxy Medicare IPO stock price potential. Here is a category-wise breakdown of the subscription as of 5:34:08 PM on September 12, 2025:

• Non-Institutional Investors (NII): 1.48 times.
• QIB Category: 1.00 times.

Galaxy Medicare Share Price and Investment Details

The Galaxy Medicare IPO stock price band was set at ₹51 to ₹54 per share with a minimum lot size of 2,000 shares. The minimum investment required for individual investors was ₹2,16,000 for 2 lots (4,000 shares). The issue included up to 2,08,000 shares reserved for market maker raising ₹1.12 crore. Given the weak subscription response of 1.83 times overall, with QIB category showing minimal response at 1.00 times and individual investors demonstrating weak response at 2.10 times, the Galaxy Medicare IPO share price is expected to list with minimal to no premium.

Utilisation of IPO Proceeds

The IPO is a complete offer for sale. Hence, the company will not receive any proceeds. The objective of the issue is to:

• Funding Capital Expenditure requirement towards purchase of machinery for existing manufacturing facility at Bhubaneswar, Odisha: ₹4.89 crore.
• Funding the working capital requirements: ₹8.94 crore.
• General corporate purposes and offer related expenses: Remaining amount.

Business Overview

Galaxy Medicare Limited operates with experienced leadership and skilled management team, established reputation and customer relationships, focus on consistently meeting quality standards, well-established manufacturing facility with wide range of products, in-house quality assurance and quality control with research and development capabilities, and international market presence while serving government health departments, corporate hospitals, and private entities throughout India.

The company maintains comprehensive medical device manufacturing capabilities producing surgical dressings, plaster of Paris bandages, adhesive tapes, compression bandages, wound care solutions, gauze products, and orthopedic items using premium grade raw materials from authentic vendors. Operating in competitive medical devices and surgical dressings market, the company leverages its established manufacturing facility and quality certifications to serve both domestic and international healthcare institutions while maintaining focus on product quality and regulatory compliance across diverse medical applications.